Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (521-530 of 556) with videos related to

Pageof 56
Sort By:
Japanese Journal of Infectious Diseases|April 29, 2005
Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodiesKazuo Ohnishi, Masahiro Sakaguchi, Tomohiro Kaji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2023
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical ImplicationsTaeang Arai, Hirokazu Takahashi, Yuya Seko, et al.
Hepatology Communications|December 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver diseaseHiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada, et al.
Gastro Hep Advances|April 20, 2026
Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter StudyAsahiro Morishita, Yoshihiro Kamada, Yoshio Sumida, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 29, 2024
Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter studyAtsuhiro Morita, Nobuharu Tamaki, Haruhiko Kobashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2018
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysisHideki Fujii, Hiroyuki Kimura, Masayuki Kurosaki, et al.
JHEP Reports : Innovation in Hepatology|April 1, 2026
Single-cell fixed RNA profiling uncovers SEMA4D and LMCD1 as therapeutic targets in a liver fibrosis modelPham Minh Duc, Le Thi Thanh Thuy, Hoang Hai, et al.
Journal of Gastroenterology|March 23, 2026
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive testsKazuhito Kawata, Hirokazu Takahashi, Taeang Arai, et al.
Transplantation|June 16, 2026
Delisting From Clinical Improvement in Liver Cirrhosis: A Machine Learning Decision Tree AnalysisNicole Shu Ying Tang, Margaret L P Teng, Asvin Selvakumar, et al.
Internal Medicine (Tokyo, Japan)|January 4, 2026
Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment SettingsHitomi Takada, Nobuharu Tamaki, Hironori Ochi, et al.
Pageof 56

Showing results (521-530 of 556) with videos related to

Sort By:
Pageof 56
Japanese Journal of Infectious Diseases|April 29, 2005
Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodiesKazuo Ohnishi, Masahiro Sakaguchi, Tomohiro Kaji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2023
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical ImplicationsTaeang Arai, Hirokazu Takahashi, Yuya Seko, et al.
Hepatology Communications|December 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver diseaseHiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada, et al.
Gastro Hep Advances|April 20, 2026
Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter StudyAsahiro Morishita, Yoshihiro Kamada, Yoshio Sumida, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 29, 2024
Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter studyAtsuhiro Morita, Nobuharu Tamaki, Haruhiko Kobashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2018
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysisHideki Fujii, Hiroyuki Kimura, Masayuki Kurosaki, et al.
JHEP Reports : Innovation in Hepatology|April 1, 2026
Single-cell fixed RNA profiling uncovers SEMA4D and LMCD1 as therapeutic targets in a liver fibrosis modelPham Minh Duc, Le Thi Thanh Thuy, Hoang Hai, et al.
Journal of Gastroenterology|March 23, 2026
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive testsKazuhito Kawata, Hirokazu Takahashi, Taeang Arai, et al.
Transplantation|June 16, 2026
Delisting From Clinical Improvement in Liver Cirrhosis: A Machine Learning Decision Tree AnalysisNicole Shu Ying Tang, Margaret L P Teng, Asvin Selvakumar, et al.
Internal Medicine (Tokyo, Japan)|January 4, 2026
Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment SettingsHitomi Takada, Nobuharu Tamaki, Hironori Ochi, et al.
Pageof 56